Keltouma Driouch

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Rania El-Botty, Ludivine Morriset, Elodie Montaudon, Zakia Tariq, Anne Schnitzler, Marina Bacci, Nicla Lorito, Laura Sourd, Léa Huguet, Ahmed Dahmani, Pierre Painsec, Heloise Derrien, Sophie Vacher, Julien Masliah-Planchon, Virginie Raynal, Sylvain Baulande, Thibaut Larcher, Anne-Vincent Salomon, Guillaume Dutertre, Paul-Henri Cottu, Géraldine Gentric, Fatima Mechta-Grigoriou, Scott Hutton, Keltouma Driouch, Ivan Bièche, Andrea Morandi, Elisabetta Marangoni
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers. Nature communications 14 (1) (2023)
Florian Bonin, Aurélie Chiche, Zakia Tariq, Paula Azorin, Sébastien Nola, Rosette Lidereau, Keltouma Driouch
Kindlin-1 drives early steps of breast cancer metastasis. Cancer communications (London, England) 42 (10) (2022)
Paula Azorin, Florian Bonin, Zakia Tariq, Ambre Petitalot, Florence Coussy, Elisabetta Marangoni, Veronique Becette, Yves Denoux, Anne Vincent-Salomon, Christophe Le Tourneau, Linda Larbi Cherif, Jerzy Klijanienko, Maud Kamal, Ivan Bièche, Rosette Lidereau, Keltouma Driouch
Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types. Clinical and translational medicine 12 (4) (2022)

Keltouma Driouch.css-eqlu8i{font-size:small;padding-left:4px;}